Inhaled v subcutaneous insulin in type 1 diabetes at 12 weeks§
| Mean percentage increase from baseline | |||
|---|---|---|---|
| Outcomes | Inhaled | Subcutaneous | Difference (95% CI) |
| §Outcomes measured with Patient Satisfaction with Insulin Therapy Questionnaire; higher score = greater satisfaction. | |||
| ¶Calculated from data in article. | |||
| Overall satisfaction | 35% | 11% | 25% (6.6 to 43) |
| Convenience or ease of use | 41% | 11% | 30% (11 to 50) |
| Social comfort | 28% | 18% | 10%¶ (–15 to 35) |